Treatment-emergent tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder

被引：0

作者：

Miller, D. D. ^{[1
]}

Kim, E. ^{[1
]}

Eudicone, J. ^{[1
]}

Pikalov, A. ^{[1
]}

Vester-Blokland, E. ^{[1
]}

机构：

[1] Univ Iowa, Carver Coll Med, Iowa City, IA USA

来源：

SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：503 / 503

页数：1

共 50 条

[41] Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder
Glick, ID
Marder, SR
NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S162 - S162
[42] Quetiapine versus haloperidol decanoate for long-term treatment of schizophrenia and schizoaffective disorder
Glick, I
Marder, SR
SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 484 - 484
[43] TREATMENT-EMERGENT DEPRESSION WITH ANTIDEPRESSANTS IN PANIC DISORDER
ARONSON, TA
COMPREHENSIVE PSYCHIATRY, 1989, 30 (03) : 267 - 271
[44] Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins
She, Shenglin
Kuang, Qijie
Zheng, Yingjun
SCHIZOPHRENIA RESEARCH, 2018, 197 : 564 - 565
[45] Psychopharmacological treatment of patients with schizoaffective disorder in comparison to schizophrenia and bipolar disorder
Assion, H. J.
Schweppe, A.
Skiba, M.
Juckel, G.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S321 - S322
[46] A blinded, controlled, long-term study of the comparative incidence of treatment - Emergent tardive dyskinesia with olanzapine or haloperidol
Wright, P
Tollefson, GD
Beasley, CM
Tamura, RN
Tran, PV
Potvin, JII
SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 206 - 206
[47] Long-term treatment-emergent dyskinetic symptoms in patients treated with olanzapine and haloperidol
Street, JS
Tamura, R
Sanger, T
Tollefson, O
PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 522 - 522
[48] TARDIVE-DYSKINESIA DURING AND FOLLOWING TREATMENT WITH HALOPERIDOL, HALOPERIDOL + BIPERIDEN, THIORIDAZINE, AND CLOZAPINE
GERLACH, J
SIMMELSGAARD, H
PSYCHOPHARMACOLOGY, 1978, 59 (02) : 105 - 112
[49] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder
De Hert, M.
Kalnicka, D.
van Winkel, R.
Wampers, M.
Hanssens, L.
Van Eyck, D.
Scheen, A.
Peuskens, J.
DRUG SAFETY, 2006, 29 (10) : 1002 - 1002
[50] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
Brecher, M
SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271

← 1 2 3 4 5 →